Advanced search
Publication Cover
Expert Opinion on Pharmacotherapy Volume 12, 2011 - Issue 18
Submit an article Journal homepage
382
Views
14
CrossRef citations to date
0
Altmetric
Reviews

Treating chronic lymphocytic leukemia with thalidomide and lenalidomide

Krzysztof Giannopoulos Medical University of Lublin, Experimental Hematooncology Department, Lublin, Poland
,
Daniel Mertens University of Ulm, Department of Internal Medicine III, 89081 Ulm, Germany; Cooperation unit “Mechanisms of Leukemogenesis”, DKFZ, 69120 Heidelberg, Germany
&
Stephan Stilgenbauer Universitätsklinikum Ulm, Klinik für Innere Medizin III, Hämatologie, Onkologie, Rheumatologie und Infektionskrankheiten, Albert-Einstein-Allee 23, D-89081 Ulm, [email protected]
Pages 2857-2864 | Published online: 18 Nov 2011

Citations (14)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Punit L. Jain, Carrie Anne Orlikowski & Alessandra Ferrajoli. (2016) Lenalidomide in chronic lymphocytic leukemia. Expert Opinion on Orphan Drugs 4:9, pages 971-980.
Read now
Massimo Gentile, Anna Grazia Recchia, Carla Mazzone & Fortunato Morabito. (2012) Emerging biological insights and novel treatment strategies in multiple myeloma. Expert Opinion on Emerging Drugs 17:3, pages 407-438.
Read now

Articles from other publishers (12)

George P. Studzinski, Elzbieta Gocek, Ewa Marcinkowska & Michael Danilenko. 2024. Feldman and Pike's Vitamin D. Feldman and Pike's Vitamin D 741 795 .
Aleksandra Marchwicka, Urszula Nowak, Anna Grembowska, Agnieszka Jakuszak, Piotr Poręba & Ewa Marcinkowska. (2022) Overexpressed fibroblast growth factor receptors increase 1,25-dihydroxyvitamin D-dependent differentiation of acute myeloid leukemia cells. The Journal of Steroid Biochemistry and Molecular Biology 224, pages 106173.
Crossref
Hao Guo, Jingyi Yang, Haoran Wang, Xingchen Liu, Yanyan Liu & Keshu Zhou. (2022) Reshaping the tumor microenvironment: The versatility of immunomodulatory drugs in B-cell neoplasms. Frontiers in Immunology 13.
Crossref
Wataru Onodera, Toru Asahi & Naoya Sawamura. (2019) Positive selection of cereblon modified function including its E3 ubiquitin ligase activity and binding efficiency with AMPK. Molecular Phylogenetics and Evolution 135, pages 78-85.
Crossref
Ota Fuchs. (2019) Treatment of Lymphoid and Myeloid Malignancies by Immunomodulatory Drugs. Cardiovascular & Hematological Disorders-Drug Targets 19:1, pages 51-78.
Crossref
Thomas J. Kipps, Freda K. Stevenson, Catherine J. Wu, Carlo M. Croce, Graham Packham, William G. Wierda, Susan O'Brien, John Gribben & Kanti Rai. (2017) Chronic lymphocytic leukaemia. Nature Reviews Disease Primers 3:1.
Crossref
Hyoung Kyu Kim, Tae Hee Ko, Bayalagmaa Nyamaa, Sung Ryul Lee, Nari Kim, Kyung Soo Ko, Byoung Doo Rhee, Chul-Seung Park, Bernd Nilius & Jin Han. (2016) Cereblon in health and disease. Pflügers Archiv - European Journal of Physiology 468:8, pages 1299-1309.
Crossref
D Saulep-Easton, F B Vincent, P S Quah, A Wei, S B Ting, C M Croce, C Tam & F Mackay. (2015) The BAFF receptor TACI controls IL-10 production by regulatory B cells and CLL B cells. Leukemia 30:1, pages 163-172.
Crossref
Lesley-Ann Sutton & Richard Rosenquist. (2015) The complex interplay between cell-intrinsic and cell-extrinsic factors driving the evolution of chronic lymphocytic leukemia. Seminars in Cancer Biology 34, pages 22-35.
Crossref
Martina Seiffert. (2014) Lenalidomide, an antiproliferative CLL drug. Blood 124:10, pages 1545-1546.
Crossref
Anna Dmoszyńska. (2013) Leki immunomodulujące – przełom w leczeniu nowotworów hematologicznych. Acta Haematologica Polonica 44:4, pages 370-377.
Crossref
Angela SchulzClaudia DürrThorsten Zenz, Hartmut Döhner, Stephan Stilgenbauer, Peter LichterMartina Seiffert. (2013) Lenalidomide reduces survival of chronic lymphocytic leukemia cells in primary cocultures by altering the myeloid microenvironment. Blood 121:13, pages 2503-2511.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.